“This expansion is a result of the growing global demand for our premium quality AstaPure line of products, and of the several long-term agreements we secured with leading companies in the dietary supplement and nutrition industries,” said Efrat Kat, director of marketing and sales at Algatechnologies. “Our competitive edge lies in our exclusive proprietary and patented cultivation process. We’re the only company that produces astaxanthin in a closed system that is fully controlled and totally exposed to natural sunlight.”
The expansion of the production will take place in two stages. In the first phase, estimated to be completed by the end of 2011, the company will increase its production capacity by 30%. The second stage, estimated to be completed in 12 months, will further increase the capacity by an additional 50%.
“This expansion will allow us to not only maintain our leading position in the market, but also help us increase our use of solar energy and water reclamation, which, when combined, will enable us to offer the most natural and environmentally friendly product on the market,” said Hagay Tzur, CEO of Algatechnologies.
Together with the production expansion, the company will widen its capabilities in the development of new microalgae cultivation technologies. It is establishing a new pilot plant and beta site to enable the testing and implementation of state-of-the-art and innovative technologies for the efficient production of a variety of active ingredients, all sourced from microalgae.
Algatechnologies plans to invest in educating its customers about the health benefits of the AstaPure products, as well as conducting clinical studies to explore its unique benefits on a wide range of different health disorders.
Source: Algatechnologies
© FoodBev Media Ltd 2024